Free Trial
NASDAQ:ZIMV

ZimVie (ZIMV) Stock Price, News & Analysis

ZimVie logo
$14.17 +0.43 (+3.13%)
(As of 11/22/2024 ET)

About ZimVie Stock (NASDAQ:ZIMV)

Key Stats

Today's Range
$13.74
$14.21
50-Day Range
$13.17
$16.96
52-Week Range
$9.00
$22.40
Volume
88,090 shs
Average Volume
163,705 shs
Market Capitalization
$391.09 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$18.33
Consensus Rating
Hold

Company Overview

ZimVie Inc., together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment. The company offers dental implant systems, prosthetic and abutment products, surgical instrumentation, and kits; and patient-specific restorative solutions, such as abutments, bars, implant bridges, and hybrid restorations under the BellaTek brand name. It provides bone grafts, barrier membranes, and collagen wound care products; virtual treatment planning services, guided surgery solutions, CAD/CAM workflow systems, and intra-oral scanners; and Implant Concierge, a web-based treatment planning and surgery guide service. In addition, the company designs, manufactures, and distributes spinal fusion implants, instrumentation for various spinal procedures, biologics, and bone healing technologies. Further, it provides MIS solutions that deliver implant and instrumentation systems; and motion preservation solutions that offer non-fusion alternatives for cervical disc implant or growth modulation for anterior vertebral body tethering. The company sells its products to oral surgeons, dental specialists, general dentists, dental laboratories, and other dental organizations, including DSOs, as well as educational, medical, and governmental entities, hospitals, and surgery centers through direct sales representatives, agents, and distributors. ZimVie Inc. was incorporated in 2021 and is headquartered in Westminster, Colorado.

ZimVie Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
55th Percentile Overall Score

ZIMV MarketRank™: 

ZimVie scored higher than 55% of companies evaluated by MarketBeat, and ranked 525th out of 953 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    ZimVie has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on 1 buy rating, 1 hold rating, and 1 sell rating.

  • Amount of Analyst Coverage

    ZimVie has received no research coverage in the past 90 days.

  • Read more about ZimVie's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of ZimVie is -1.08, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of ZimVie is -1.08, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    ZimVie has a P/B Ratio of 0.96. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about ZimVie's valuation and earnings.
  • Percentage of Shares Shorted

    1.40% of the float of ZimVie has been sold short.
  • Short Interest Ratio / Days to Cover

    ZimVie has a short interest ratio ("days to cover") of 2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in ZimVie has recently decreased by 13.39%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    ZimVie does not currently pay a dividend.

  • Dividend Growth

    ZimVie does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    1.40% of the float of ZimVie has been sold short.
  • Short Interest Ratio / Days to Cover

    ZimVie has a short interest ratio ("days to cover") of 2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in ZimVie has recently decreased by 13.39%, indicating that investor sentiment is improving significantly.
    • Insider Buying vs. Insider Selling

      In the past three months, ZimVie insiders have not sold or bought any company stock.

    • Percentage Held by Insiders

      Only 3.01% of the stock of ZimVie is held by insiders.

    • Percentage Held by Institutions

      95.63% of the stock of ZimVie is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

    • Read more about ZimVie's insider trading history.
    Receive ZIMV Stock News and Ratings via Email

    Sign-up to receive the latest news and ratings for ZimVie and its competitors with MarketBeat's FREE daily newsletter.

    ZIMV Stock News Headlines

    ZimVie Inc (ZIMV) Gets a Sell from Barclays
    ZimVie Reports Third Quarter 2024 Financial Results
    Trump won. Buy this coin now.
    Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.
    ZimVie Inc. (ZIMV) Q3 2024 Earnings Call Transcript
    ZimVie Inc. Reports Improved Q3 Financial Performance
    See More Headlines

    ZIMV Stock Analysis - Frequently Asked Questions

    ZimVie's stock was trading at $17.75 on January 1st, 2024. Since then, ZIMV stock has decreased by 20.2% and is now trading at $14.17.
    View the best growth stocks for 2024 here
    .

    ZimVie Inc. (NASDAQ:ZIMV) posted its quarterly earnings data on Thursday, August, 1st. The company reported $0.13 EPS for the quarter, missing the consensus estimate of $0.17 by $0.04. The company had revenue of $116.81 million for the quarter. ZimVie had a positive trailing twelve-month return on equity of 2.90% and a negative net margin of 77.31%.

    Top institutional shareholders of ZimVie include Geode Capital Management LLC (2.34%), State Street Corp (2.30%), Charles Schwab Investment Management Inc. (1.98%) and Jacobs Levy Equity Management Inc. (1.44%). Insiders that own company stock include Camber Capital Management Lp, Vafa Jamali and Richard Heppenstall.
    View institutional ownership trends
    .

    Shares of ZIMV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
    Compare Top Brokerages Here.

    Based on aggregate information from My MarketBeat watchlists, some other companies that ZimVie investors own include Chevron (CVX), Comcast (CMCSA), Bristol-Myers Squibb (BMY), McKesson (MCK), Charles Schwab (SCHW), Edwards Lifesciences (EW) and Yum! Brands (YUM).

    Company Calendar

    Last Earnings
    8/01/2024
    Today
    11/22/2024
    Fiscal Year End
    12/31/2024
    Next Earnings (Estimated)
    2/26/2025

    Industry, Sector and Symbol

    Sector
    Medical
    Industry
    Dental equipment & supplies
    Sub-Industry
    Medical Equipment
    Current Symbol
    NASDAQ:ZIMV
    Fax
    N/A
    Employees
    2,600
    Year Founded
    N/A

    Price Target and Rating

    Average Stock Price Target
    $18.33
    High Stock Price Target
    $23.00
    Low Stock Price Target
    $16.00
    Potential Upside/Downside
    +29.4%
    Consensus Rating
    Hold
    Rating Score (0-4)
    2.00
    Research Coverage
    3 Analysts

    Profitability

    Net Income
    $-393,280,000.00
    Pretax Margin
    -8.39%

    Debt

    Sales & Book Value

    Annual Sales
    $457.43 million
    Cash Flow
    $5.17 per share
    Book Value
    $14.73 per share

    Miscellaneous

    Free Float
    26,768,000
    Market Cap
    $391.09 million
    Optionable
    Optionable
    Beta
    2.14
    10 Best Cheap Stocks to Buy Now Cover

    MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

    Get This Free Report

    This page (NASDAQ:ZIMV) was last updated on 11/23/2024 by MarketBeat.com Staff
    From Our Partners